|
We have examined with BeMS how to intorduce antibody-production
technology by DNA immunization and the way to launch its business.
The technology was invented by Taizo Taniguchi, M.D., Ph.D.,
who is a director of BeMS, a venture firm originated
in Kobe University.
We have recently completed examining usefulness of the technology
and concluded a license agreement with BeMS in order for us to
start the related business.
Unlike an immunization method in which protein and peptides are
used as antigens, expression vectors which encode objective proteins
are directly injected in animals in this technology. Therefore,
the antigens easily retain their original structures in vivo, enabling
us to produce high value-added antibodies.
We will provide this technology as a custom-made antibody-production
service. Moreover, combining it with our fundamental technology
for producing a high-affinity antibodies (GANP® Mouse Technology),
we aim to develop even more useful antibody-producing technologies
in order to apply them to the fields of diagnostic reagents and
pharmaceutics.
|
